Detailed assessment of rare and common TERT variation in a family with a telomere biology disorder
Year: 2025
Type: article
Study design: Observational Study
Abstract: Telomere biology disorders (TBDs) are caused by rare pathogenic variants in telomere maintenance genes and often present with variable penetrance of multi-organ system manifestations. We evaluated a family with 14 individuals heterozygous for TERT c.2591T>C (p.L864P) and 13 non-carriers. TRAP assays showed that p.L864P causes a complete loss of telomerase activity. Carriers had shorter lymphocyte telomeres than non-carriers. Carriers presented different TBD manifestations, but had similar telomere length (TL) distributions, suggesting variable penetrance and possible genetic anticipation. Somatic TERT promoter mutations were detected in four carriers aged >50 years (variant allele fractions <4% in three and 18%-19% in one). Exome sequencing did not identify other variants of interest. Although not statistically significant, polygenic scores derived from common TL-associated genetic variation were lower in c.2591T>C carriers with more TBD clinical manifestations. Alleles associated with alternative TERT splicing, VNTR6-1-Long and rs10069690-T, co-segregated with c.2591T>C. This haplotype was associated with a reduction in TL Z score (β = -1.81, p < 0.0001). Another haplotype, c.2591T, VNTR6-1-Long, and rs10069690-T, demonstrated an independent reduction of TL Z score (β = -0.84, p = 0.0111). The TBD manifestations in this family may relate to common TL-associated genetic variation and alternative TERT splicing, emphasizing the importance of investigations into TBD manifestations within and between TBD families.
Institutions: National Institutes of Health, Frederick National Laboratory for Cancer Research, Division of Cancer Epidemiology and Genetics, Leidos Biomedical Research Inc. (United States), National Cancer Institute, Washington University in St. Louis, Broad Institute, Boston Children's Hospital, Howard Hughes Medical Institute, Harvard University, Dana-Farber Cancer Institute, Rutgers New Jersey Medical School
Language: English
Subfield: Cell Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,300
OpenAlex ID: W4415547760
